Recombinant Staphylococcus aureus Lysine--tRNA ligase (lysS)

What is the role of Staphylococcus aureus lysS in bacterial metabolism?

Staphylococcus aureus Lysine--tRNA ligase (lysS) is an essential aminoacyl-tRNA synthetase that catalyzes the attachment of lysine to its cognate tRNA molecules. While its primary function is providing charged lysyl-tRNAs for protein synthesis, in S. aureus these charged tRNAs serve additional crucial metabolic functions.

One significant non-canonical role is supplying lysyl-tRNA for lysylphosphatidylglycerol (LPG) synthesis. Research has shown that the S. aureus MprF protein (LPG synthetase) transfers lysine from lysyl-tRNA to phosphatidylglycerol (PG), creating the positively charged membrane lipid LPG . This modification contributes to bacterial membrane charge and affects interactions with host defense molecules and antibiotics.

Lysyl-tRNA in S. aureus also indirectly contributes to peptidoglycan biosynthesis, as lysine is incorporated into the third position of peptidoglycan stem peptides by the MurE enzyme, distinguishing S. aureus peptidoglycan from that of Gram-negative bacteria, which typically use diaminopimelic acid (DAP) in this position .

How does lysine incorporation in S. aureus peptidoglycan differ from other bacterial species?

The incorporation of lysine into peptidoglycan is a distinctive feature of S. aureus cell wall synthesis. In Gram-negative bacteria like Escherichia coli, MurE incorporates meso-diaminopimelic acid (mDAP) at the third position of the peptidoglycan stem peptide, while S. aureus MurE incorporates L-lysine .

Interestingly, structural studies of S. aureus MurE at 1.8 Å resolution have revealed that this specificity is not primarily due to enzyme structure. Analysis of S. aureus MurE complexed with UDP-MurNAc-L-Ala-γ-D-Glu-L-Lys and ADP showed that despite a consensus sequence previously implicated in substrate selection, the enzyme actually shows limited specificity for lysine within its active site .

Instead, S. aureus compensates for this relatively poor binding of lysine through high cytoplasmic lysine concentrations. Metabolomic data confirm that elevated intracellular lysine levels, rather than strict enzyme specificity, drive lysine incorporation . This represents an intriguing example of how both metabolic and structural constraints maintain cell wall integrity in S. aureus.

Furthermore, after lysine incorporation by MurE, S. aureus requires additional modification by Fem ligases (FemX, -A, -B), which add a pentaglycine side chain to the ε-amino group of the incorporated lysine, creating a structure essential for proper cell wall cross-linking .

What enzymatic properties distinguish S. aureus lysS from lysyl-tRNA synthetases in other species?

S. aureus lysS exhibits several distinctive enzymatic properties that reflect its adaptation to the specific metabolic requirements of this pathogen:

• Dual-purpose aminoacylation: Unlike many other bacterial species, S. aureus lysS must produce charged lysyl-tRNAs for both protein synthesis and membrane lipid modification through LPG synthesis .

• Kinetic parameters: While the search results don't provide specific kinetic parameters for lysS itself, related enzymes in the lysine utilization pathway show distinctive kinetic properties. For example, the LPG synthetase that uses lysyl-tRNA has Km values of 56 μM for PG and 6.9 μM for lysyl-tRNA , indicating relatively high affinity for the lysyl-tRNA product of lysS.

• Metal ion requirements: Like other aminoacyl-tRNA synthetases, S. aureus lysS likely requires divalent metal ions (typically Mg²⁺) for catalysis, which coordinate ATP during the aminoacylation reaction.

• Sensitivity to cellular lysine pools: Given that S. aureus relies on high cytoplasmic lysine concentrations for processes like peptidoglycan synthesis , lysS likely operates in an environment with higher lysine concentrations than similar enzymes in other bacterial species.

• Potential regulation by posttranslational modifications: Recent research has identified extensive lysine succinylation and acetylation in S. aureus, with 75% of succinylation sites also being targets for acetylation . While direct evidence for lysS modification is not provided in the search results, these widespread PTMs suggest potential regulatory mechanisms affecting lysS activity.

What expression systems are most effective for producing recombinant S. aureus lysS?

Based on successful expression strategies for other S. aureus enzymes, the following approaches are recommended for recombinant S. aureus lysS production:

E. coli Expression Systems:

• Strain selection: BL21(DE3) and derivatives are generally suitable for expressing S. aureus proteins . The BL21(DE3) pLysS strain may provide better control over expression for potentially toxic proteins.

• Vector design considerations:

  • Include a purification tag (His₆, MBP, or GST)

  • Use a strong inducible promoter (T7 or tac)

  • Consider codon optimization for E. coli if expression is poor

• Optimization parameters:

  • Induction temperature: Often lower temperatures (16-20°C) improve solubility

  • IPTG concentration: 0.1-0.5 mM typically, but may require optimization

  • Induction duration: 4-16 hours depending on temperature

  • Media composition: Rich media (TB, 2×YT) often improves yield

• Extraction and solubilization:

  • Lysis buffer composition is critical for maintaining enzyme activity

  • Include protease inhibitors, reducing agents, and glycerol

  • Magnesium ions (5-10 mM MgCl₂) are essential for aminoacyl-tRNA synthetase stability

This approach has been successful for similar S. aureus enzymes like PcrA helicase, which was functionally expressed in E. coli for biochemical characterization and inhibitor screening .

What assays can accurately measure S. aureus lysS enzymatic activity?

Several complementary assays can be employed to measure S. aureus lysS activity with varying degrees of sensitivity and information content:

1. ATP-PPi Exchange Assay:

• Principle: Measures the first step of aminoacylation (amino acid activation)

• Advantages: Well-established, relatively simple

• Limitations: Does not confirm tRNA charging

• Protocol outline:

  • Reaction contains lysS, lysine, ATP, Mg²⁺, and [³²P]PPi

  • Formation of [³²P]ATP indicates amino acid activation

  • Quantify labeled ATP by thin-layer chromatography or charcoal binding

2. Direct Aminoacylation Assay:

• Principle: Measures formation of lysyl-tRNA using labeled lysine

• Advantages: Directly measures complete reaction

• Protocol outline:

  • Reaction contains lysS, tRNA^Lys, [³H] or [¹⁴C]lysine, ATP, and Mg²⁺

  • Precipitate charged tRNA with TCA on filter papers

  • Quantify incorporated radioactivity by scintillation counting

3. Acid Gel Electrophoresis:

• Principle: Separates charged from uncharged tRNAs

• Advantages: Non-radioactive, can use native tRNA

• Protocol outline:

  • Run reaction with unlabeled components

  • Separate products on acid urea polyacrylamide gel

  • Visualize tRNA by methylene blue staining or northern blotting

4. Malachite Green Assay:

• Principle: Detects inorganic phosphate released from pyrophosphate

• Advantages: High-throughput compatible, no radioactivity

• Protocol outline:

  • Couple reaction with pyrophosphatase to generate Pi

  • Detect Pi colorimetrically using malachite green reagent

  • Measure absorbance at 620-640 nm

When establishing these assays, it's important to determine kinetic parameters (Km, kcat) for each substrate to characterize the enzyme. For comparison, the related enzyme LPG synthetase, which uses lysyl-tRNA as a substrate, has Km values of 56 μM for PG and 6.9 μM for lysyl-tRNA .

How can researchers effectively purify active S. aureus lysS for structural and functional studies?

Purification of active S. aureus lysS requires careful consideration of buffer conditions and handling procedures to maintain enzyme integrity:

Purification Protocol:

• Cell Lysis:

  • Buffer composition: 50 mM Tris-HCl pH 7.5-8.0, 300 mM NaCl, 5-10 mM MgCl₂, 10% glycerol, 1 mM DTT, protease inhibitors

  • Lysis methods: Sonication or pressure-based (French press, EmulsiFlex)

  • Clarification: High-speed centrifugation (40,000×g, 30-45 min)

• Affinity Chromatography:

  • For His-tagged protein:

    • Ni-NTA or TALON resin

    • Binding buffer: Lysis buffer + 10-20 mM imidazole

    • Wash buffer: Lysis buffer + 20-50 mM imidazole

    • Elution buffer: Lysis buffer + 250-300 mM imidazole

• Ion Exchange Chromatography:

  • Typically anion exchange (Q Sepharose)

  • Buffer: 20 mM Tris-HCl pH 7.5-8.0, 5 mM MgCl₂, 10% glycerol, 1 mM DTT

  • Elution: Linear NaCl gradient (0-500 mM)

• Size Exclusion Chromatography:

  • Superdex 200 or Sephacryl S-200

  • Buffer: 20 mM HEPES pH 7.5, 150 mM NaCl, 5 mM MgCl₂, 10% glycerol, 1 mM DTT

Critical Considerations:

• Maintaining enzyme activity:

  • Keep samples at 4°C throughout purification

  • Include Mg²⁺ in all buffers (essential for aminoacyl-tRNA synthetases)

  • Add reducing agents to prevent oxidation of cysteine residues

  • Include glycerol (10%) to stabilize the protein

• Quality assessment:

  • Purity: SDS-PAGE, mass spectrometry

  • Homogeneity: Dynamic light scattering, analytical size exclusion

  • Activity: Perform activity assays after each purification step

  • Structural integrity: Circular dichroism

• Storage conditions:

  • Flash freeze in liquid nitrogen

  • Store at -80°C in small aliquots

  • Add additional glycerol (up to 20%) for freezing

  • Validate activity after freeze-thaw cycle

Similar approaches have been successful for other S. aureus enzymes, including PcrA helicase, which was purified for biochemical characterization and inhibitor screening .

How does S. aureus lysS contribute to lysylphosphatidylglycerol synthesis and antimicrobial resistance?

S. aureus lysS plays a crucial indirect role in lysylphosphatidylglycerol (LPG) synthesis by providing the essential lysyl-tRNA substrate, linking protein synthesis machinery to membrane lipid modification and antimicrobial resistance:

Biochemical Pathway:

• lysS catalyzes the attachment of lysine to tRNA^Lys, producing lysyl-tRNA^Lys

• The MprF protein (LPG synthetase) transfers the lysine moiety from lysyl-tRNA^Lys to phosphatidylglycerol (PG)

• This produces lysylphosphatidylglycerol, a positively charged membrane lipid

Experimental Evidence:

• Wild-type S. aureus membrane fractions demonstrate LPG synthetase activity dependent on PG and lysyl-tRNA, while mprF deletion mutants lack this activity

• Expression of S. aureus MprF in E. coli induces LPG synthesis, but only when sufficient PG is available

• Biochemical characterization shows the Km values of LPG synthetase for its substrates are 56 μM for PG and 6.9 μM for lysyl-tRNA

Contribution to Antimicrobial Resistance:

• Membrane charge modification: LPG introduces positive charges into the membrane, reducing the net negative charge

• Reduced binding of cationic antimicrobials: The altered membrane charge decreases affinity for cationic antimicrobial peptides (CAMPs) and certain antibiotics

• Altered membrane permeability: LPG modification affects membrane fluidity and permeability properties

• Resistance to host defense mechanisms: Decreased susceptibility to CAMPs produced by neutrophils and epithelial cells

This pathway represents a unique intersection between protein synthesis and membrane modification systems, making lysS indirectly important for antimicrobial resistance. Inhibition of lysS could potentially affect both protein synthesis and membrane modification, making it an attractive dual-action target for antimicrobial development.

How do posttranslational modifications affect lysine metabolism and potentially lysS function in S. aureus?

Recent research has revealed extensive posttranslational modifications (PTMs) of lysine residues in S. aureus proteins, with potential implications for lysS function and lysine metabolism:

Major Lysine PTMs in S. aureus:

• Lysine succinylation (Ksucc): Addition of a succinyl group (-CO-CH₂-CH₂-COOH) to lysine residues

• Lysine acetylation (Kac): Addition of an acetyl group (-COCH₃) to lysine residues

Key Findings from PTM Studies:

• Quantitative analysis in vancomycin-intermediate S. aureus (VISA) strain XN108 identified 3,260 succinylation sites

• 75% (2,445) of succinylation sites were also targets of acetylation, indicating extensive cross-talk between these modifications

• The enzyme SaCobB has been identified as bifunctional, possessing both deacetylation and desuccinylation activities

• These PTMs regulate numerous metabolic pathways including glycolysis, TCA cycle, oxidative phosphorylation, and protein biosynthesis

Potential Implications for lysS Function:

• Direct regulation: If lysS itself undergoes PTMs on key lysine residues, its activity could be directly modulated

• Substrate availability: Modifications affecting lysine metabolism could alter free lysine pools available for aminoacylation

• tRNA interactions: PTMs might affect lysS interactions with tRNA or other components of the translation machinery

• Cross-talk with other systems: Given the extensive overlap between succinylation and acetylation , lysS could be integrated into broader regulatory networks

Table 1: Comparison of Major Lysine PTMs in S. aureus

Understanding how these PTMs affect lysS and related enzymes could reveal new regulatory mechanisms and potential intervention points for antimicrobial development.

What structural features of S. aureus lysS could be exploited for selective inhibitor design?

While the search results don't provide direct structural information about S. aureus lysS, insights can be derived from related aminoacyl-tRNA synthetases and S. aureus enzymes that could guide inhibitor design:

Potential Structural Features for Targeting:

• Active Site Architecture:

  • The ATP binding pocket is typically highly conserved but may contain subtle species-specific features

  • The amino acid binding pocket must accommodate lysine and discriminate against other amino acids

  • The tRNA binding domain includes features that recognize the specific structure of tRNA^Lys

• Species-Specific Elements:

  • Similar to MurE, which shows species-specific substrate selection mechanisms , lysS likely contains unique structural elements that distinguish it from human homologs

  • Research on S. aureus MurE revealed that lysine selection involves a binding pocket based on charge characteristics rather than a straightforward consensus sequence

• Conformational Dynamics:

  • Aminoacyl-tRNA synthetases undergo significant conformational changes during catalysis

  • These movements may create transient pockets that could be targeted by small molecules

  • Inhibitors that lock the enzyme in non-productive conformations could be effective

• Allosteric Sites:

  • Regulatory sites distinct from the active site could provide selective targeting opportunities

  • In other aminoacyl-tRNA synthetases, such sites have been identified and exploited for inhibitor design

Rational Design Approaches:

• Structure-based design: When crystal structures become available, computational methods can identify unique pockets and design complementary inhibitors

• Fragment-based screening: Identify small chemical fragments that bind to different regions of lysS, then link or grow these fragments into more potent inhibitors

• Transition state analogs: Design compounds that mimic the transition state of the aminoacylation reaction

• Dual-targeting approaches: Design inhibitors that simultaneously target lysS and related enzymes in lysine metabolism pathways

• Allosteric modulators: Identify compounds that bind outside the active site but affect enzyme function

The high-resolution structural characterization of other S. aureus enzymes, such as MurE at 1.8 Å resolution , demonstrates the feasibility of obtaining detailed structural information about S. aureus enzymes for drug design purposes.

What are common challenges in recombinant S. aureus lysS expression and how can they be resolved?

Expressing recombinant S. aureus proteins in heterologous systems presents several challenges that require systematic troubleshooting:

Challenge 1: Poor Protein Solubility

• Symptoms: Majority of protein in inclusion bodies; little protein in soluble fraction

• Solutions:

  • Lower induction temperature (16-20°C)

  • Reduce inducer concentration (0.1-0.2 mM IPTG)

  • Use solubility-enhancing fusion tags (MBP, SUMO, TrxA)

  • Add osmolytes to growth media (sorbitol, glycine betaine)

  • Try autoinduction media instead of IPTG induction

  • Co-express with molecular chaperones (GroEL/ES, DnaK/DnaJ/GrpE)

Challenge 2: Low Enzymatic Activity

• Symptoms: Protein appears soluble but shows little or no activity

• Solutions:

  • Ensure buffer contains essential cofactors (Mg²⁺)

  • Add reducing agents to prevent oxidation of catalytic cysteines

  • Optimize purification to minimize exposure to harsh conditions

  • Test different pH ranges for maximal activity

  • Check protein folding using circular dichroism

  • Consider expression as fusion protein with cleavable tag

Challenge 3: Proteolytic Degradation

• Symptoms: Multiple bands on SDS-PAGE; decreasing yield during purification

• Solutions:

  • Include protease inhibitors in all buffers

  • Use protease-deficient E. coli strains (BL21)

  • Minimize time between cell disruption and first purification step

  • Maintain low temperature (4°C) throughout purification

  • Add stabilizing agents (glycerol, arginine, glutamate)

Challenge 4: Inconsistent Activity Measurements

• Symptoms: Variable results between assays; activity declines rapidly

• Solutions:

  • Standardize all assay components and conditions

  • Use freshly prepared ATP solutions

  • Ensure tRNA is properly folded

  • Include internal standards or control reactions

  • Evaluate enzyme stability under assay conditions

  • Determine optimal storage conditions

Challenge 5: Low Expression Yield

• Symptoms: Low protein levels despite good cell growth

• Solutions:

  • Optimize codon usage for E. coli

  • Try different E. coli expression strains

  • Test alternate promoters or expression vectors

  • Use richer growth media (TB, 2×YT)

  • Extend induction time at lower temperatures

  • Screen for optimal cell density at induction

Similar challenges have been addressed when expressing other S. aureus enzymes, such as PcrA helicase, which was successfully expressed in E. coli for biochemical characterization .

How can researchers distinguish between the effects of lysS inhibition and other metabolic perturbations in S. aureus?

Distinguishing specific effects of lysS inhibition from broader metabolic disturbances requires multi-level experimental approaches:

Genetic Approaches:

• Conditional expression systems:

  • Place lysS under an inducible promoter to create titratable expression levels

  • Compare phenotypes under partial depletion with potential inhibitor effects

  • Establish dose-dependent relationships between lysS activity and cellular phenotypes

• Point mutations:

  • Create catalytically impaired but structurally intact lysS variants

  • Mutations in ATP binding, lysine binding, or tRNA interaction sites

  • Compare phenotypes with inhibitor treatment effects

Biochemical Markers:

• Direct measures of aminoacylation:

  • Quantify charged vs. uncharged tRNA^Lys levels using acid gel electrophoresis

  • Measure aminoacylation rates in cell extracts

  • Track incorporation of labeled lysine into tRNA

• Downstream processes:

  • Monitor LPG levels in membranes, which depend on lysyl-tRNA availability

  • Assess lysine incorporation into peptidoglycan, which depends on cytoplasmic lysine pools

  • Measure protein synthesis rates using pulse-labeling techniques

Control Experiments:

• Comparative inhibitor studies:

  • Test known translation inhibitors with different mechanisms (e.g., chloramphenicol, erythromycin)

  • Compare response profiles to distinguish lysS-specific effects

  • Use structurally related but inactive compounds as negative controls

• Metabolic supplementation:

  • Test if exogenous lysine can rescue specific phenotypes

  • Determine if alternate metabolic pathways can compensate for lysS inhibition

Temporal Analysis:

• Time-course studies:

  • Track the sequence of metabolic changes following lysS inhibition

  • Early effects are more likely to be direct consequences

  • Later effects may represent adaptive responses or secondary damage

• Pulse-inhibition experiments:

  • Brief exposure to inhibitors to capture immediate effects

  • Analyze recovery dynamics after inhibitor removal

By combining these approaches, researchers can build a comprehensive profile of lysS-specific effects and distinguish them from general stress responses or secondary metabolic perturbations.

What analytical methods are best suited for studying the role of lysS in lysine-dependent pathways in S. aureus?

Multiple analytical techniques can be employed to investigate how lysS contributes to lysine utilization in various S. aureus cellular processes:

Transcriptomic and Proteomic Approaches:

• RNA-Seq analysis:

  • Compare transcriptional profiles under lysS limitation or inhibition

  • Identify compensatory pathways activated in response to lysS perturbation

  • Measure co-regulation patterns between lysS and genes involved in lysine metabolism

• Ribosome profiling:

  • Assess translation efficiency changes when lysS activity is limited

  • Identify lysine codon-specific pausing or drop-off events

  • Evaluate alterations in the cellular translatome

• Proteomics with PTM Analysis:

  • Quantify changes in lysine succinylation and acetylation patterns

  • Determine if lysS itself undergoes regulatory PTMs

  • Analyze changes in protein abundance in lysine-rich proteins

Metabolic Analysis:

• Amino acid pool quantification:

  • Measure free lysine levels under different conditions

  • Track isotope-labeled lysine to follow metabolic fate

  • Compare with S. aureus MurE studies showing dependence on high cytoplasmic lysine concentrations

• tRNA charging analysis:

  • Acid gel electrophoresis to separate charged from uncharged tRNAs

  • Northern blotting with tRNA^Lys-specific probes

  • tRNA microarray analysis to profile global tRNA charging status

• Lipid analysis:

  • Quantify LPG and PG levels in membranes under lysS perturbation

  • Mass spectrometry to identify altered lipid compositions

  • Correlate membrane composition changes with antimicrobial susceptibility

Functional Assays:

• Peptidoglycan analysis:

  • HPLC or mass spectrometry to quantify lysine incorporation into peptidoglycan

  • Assess changes in cross-linking patterns when lysine availability is altered

  • Compare with studies of MurE function in lysine incorporation

• Membrane function tests:

  • Membrane permeability assays using fluorescent dyes

  • Surface charge measurements using zeta potential analysis

  • Antimicrobial peptide binding and killing efficiency tests

• Enzyme activity profiles:

  • In vitro reconstitution of lysine-dependent pathways

  • Competition assays between different lysine-utilizing enzymes

  • Kinetic analysis of lysyl-tRNA partitioning between protein synthesis and LPG formation

By integrating these analytical approaches, researchers can build a comprehensive understanding of how lysS activity influences multiple lysine-dependent pathways in S. aureus metabolism.

How do bacteria balance lysyl-tRNA utilization between protein synthesis and non-canonical functions?

The dual utilization of lysyl-tRNA for both protein synthesis and cell envelope modification presents an intriguing regulatory challenge for S. aureus. Current research is investigating several mechanisms that may govern this balance:

Potential Regulatory Mechanisms:

• Spatial organization:

  • Localization of MprF near the membrane may create a distinct pool of lysyl-tRNA dedicated to LPG synthesis

  • Co-localization of lysS with different cellular machinery might direct the fate of its products

  • Membrane association of a subset of lysS enzymes could create functionally distinct populations

• Temporal regulation:

  • Growth phase-dependent expression of lysS versus MprF

  • Stress-responsive modulation of competing pathways

  • Circadian or metabolic cycle influences on pathway priorities

• Kinetic competition:

  • Differential affinity of EF-Tu versus MprF for lysyl-tRNA

  • The Km of LPG synthetase for lysyl-tRNA (6.9 μM) provides a reference point for this competition

  • Rate-limiting steps in each pathway that affect lysyl-tRNA consumption

• Allosteric regulation:

  • Feedback inhibition based on end-product concentrations

  • Allosteric activation of lysS or competing enzymes based on cellular needs

  • Small molecule effectors that modulate pathway preferences

• Post-translational control:

  • Modifications of lysS or MprF that affect activity or substrate recognition

  • Potential role of the extensive lysine acetylation and succinylation networks in S. aureus

  • Regulation by proteolysis or other PTMs

Current Research Questions:

• How does S. aureus maintain adequate lysyl-tRNA supply for both pathways under different growth conditions?

• Do stresses that affect one pathway (protein synthesis or membrane modification) result in compensatory changes in the other?

• Can the balance be shifted therapeutically to enhance antimicrobial effectiveness?

Understanding these regulatory mechanisms could reveal new approaches to disrupt S. aureus adaptation and survival strategies.

What are promising approaches for targeting S. aureus lysS in antimicrobial development?

The essential nature of lysS and its indirect contribution to multiple cellular processes makes it an attractive target for novel antimicrobial development:

Target Validation Evidence:

• Aminoacyl-tRNA synthetases are essential enzymes with no human cytoplasmic homologs

• lysS indirectly contributes to membrane modification through LPG synthesis

• Its product lysyl-tRNA feeds into peptidoglycan synthesis pathways

• Multiple cellular processes depend on lysS activity, potentially limiting resistance development

Inhibitor Development Strategies:

• Active site inhibitors:

  • Design of ATP-competitive compounds that exploit differences between bacterial and human lysyl-tRNA synthetases

  • Development of lysine analogs that compete for the amino acid binding pocket

  • Creation of bisubstrate analogs that mimic the aminoacylation transition state

• Allosteric inhibitors:

  • Identification of S. aureus-specific regulatory sites on lysS

  • Screening for compounds that bind to these sites and modulate enzyme function

  • Development of inhibitors that lock the enzyme in inactive conformations

• Dual-targeting approaches:

  • Design of molecules that simultaneously inhibit lysS and MprF, disrupting both protein synthesis and membrane modification

  • Compounds that target lysS and MurE to affect both translation and cell wall synthesis

  • Combination strategies targeting lysS and the enzymes involved in lysine biosynthesis

• Pathway-specific inhibition:

  • Compounds that selectively block lysyl-tRNA utilization by MprF without affecting protein synthesis

  • Development of inhibitors that alter the balance between competing pathways

  • Exploitation of S. aureus's dependence on high cytoplasmic lysine levels

Screening Approaches:

• High-throughput enzymatic assays measuring ATP consumption or pyrophosphate release

• Cell-based screens monitoring both growth inhibition and LPG synthesis

• Fragment-based drug discovery targeting various domains of lysS

• Virtual screening against homology models based on related aminoacyl-tRNA synthetases

The interdependence of multiple essential pathways on lysS function makes it a particularly attractive target for addressing the growing challenge of multi-drug resistant S. aureus infections.

How does lysS contribute to S. aureus adaptation to host environments and antibiotic exposure?

S. aureus lysS plays multifaceted roles in bacterial adaptation to host environments and antibiotic stresses, though these relationships remain areas of active investigation:

Host Environment Adaptation:

• Immune evasion:

  • By providing lysyl-tRNA for LPG synthesis , lysS indirectly contributes to resistance against host antimicrobial peptides

  • Altered membrane charge reduces binding of cationic immune molecules

  • Modified cell surface properties may affect recognition by immune receptors

• Colonization capacity:

  • S. aureus prevalence in the human nares (42.5%) and throat (42.7%) may depend partly on adaptations mediated by lysS-dependent processes

  • Cell wall and membrane modifications contribute to adherence and biofilm formation

  • Protein synthesis adaptation to nutrient availability in host niches

• pH and ionic strength adaptation:

  • LPG synthesis enables adaptation to varying pH and salt conditions in different host sites

  • Membrane charge modulation affects proton gradient maintenance

  • Translation adaptation to ionic conditions of host environments

Antibiotic Resistance Contributions:

• Direct resistance mechanisms:

  • LPG synthesis reduces susceptibility to cationic antimicrobial peptides and certain antibiotics

  • Altered peptidoglycan structure affects binding of cell wall-targeting antibiotics

  • Modifications in translation machinery can impact sensitivity to protein synthesis inhibitors

• Adaptive responses:

  • Stress-responsive regulation of lysS may allow adaptation to antibiotic pressure

  • Altered balance between protein synthesis and cell envelope modification

  • Potential role in persistence through modulation of translation rates

• Phenotypic heterogeneity:

  • Variability in lysS expression or activity could contribute to population heterogeneity

  • Subpopulations with different lysine utilization patterns may have varying antibiotic tolerance

  • Bet-hedging strategies involving lysS-dependent pathways

Research Questions Driving Current Investigations:

• How does lysS expression and activity change during infection and colonization?

• Do antibiotics targeting different cellular processes indirectly affect lysS function?

• Can targeting lysS enhance the effectiveness of existing antibiotics?

• How do posttranslational modifications regulate lysS function during adaptation ?

Understanding these complex relationships could reveal new strategies for disrupting S. aureus adaptation mechanisms and enhancing treatment efficacy.